C/EBPβ has been implied to play a pro-oncogenic role in several other types of cancer, including mammary, skin, intestinal, and bladder cancer, as well as in acute myeloid leukemia (AML) and lymphoma [15–20]. Here, CEBPB is linked to cancer.